Shane G. Supple

840 total citations
6 papers, 224 citations indexed

About

Shane G. Supple is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shane G. Supple has authored 6 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shane G. Supple's work include Acute Myeloid Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Shane G. Supple is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Shane G. Supple collaborates with scholars based in Australia, United Kingdom and Finland. Shane G. Supple's co-authors include John F. Seymour, George D. Demetri, Amy Harlow, Arin McKinley, Lilla Di Scala, Christopher L. Corless, A. van Oosterom, Zariana Nikolova, Jonathan A. Fletcher and Ajia Town and has published in prestigious journals such as Blood, Clinical Cancer Research and British Journal of Haematology.

In The Last Decade

Shane G. Supple

6 papers receiving 218 citations

Peers

Shane G. Supple

MB

PRM

HEMAT

ONCOL

RHEUM

Davide Mari Italy

Liviawati Sutjandra United States

Tuochuan Dong United States

Sachi Morita Japan

Mohammed Jaloudi United States

Stephen Chanock United States

Xing Sun United States

Teresa Staiano Italy

Yanyan Zhu United States

José González Spain

Davide Mari Italy

Shane G. Supple

210 ×2.7

MB

83 ×1.2

PRM

19 ×0.3

HEMAT

115 ×2.6

ONCOL

65 ×1.5

RHEUM

Citations per year, relative to Shane G. Supple Shane G. Supple (= 1×) peers Davide Mari

Countries citing papers authored by Shane G. Supple

Since Specialization

Citations

This map shows the geographic impact of Shane G. Supple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane G. Supple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane G. Supple more than expected).

Fields of papers citing papers by Shane G. Supple

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane G. Supple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane G. Supple. The network helps show where Shane G. Supple may publish in the future.

Co-authorship network of co-authors of Shane G. Supple

This figure shows the co-authorship network connecting the top 25 collaborators of Shane G. Supple. A scholar is included among the top collaborators of Shane G. Supple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane G. Supple. Shane G. Supple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Iland, Harry, Marnie Collins, Mark Hertzberg, et al.. (2014). Final Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 Trial: All-Trans Retinoic Acid (ATRA), Intravenous Arsenic Trioxide (ATO) and Idarubicin (IDA) As Initial Therapy for Acute Promyelocytic Leukemia (APL). Blood. 124(21). 375–375. 3 indexed citations

2.

Iland, Harry, K. F. Bradstock, John F. Seymour, et al.. (2011). Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia. Haematologica. 97(2). 227–234. 42 indexed citations

3.

Heinrich, Michael C., Heikki Joensuu, George D. Demetri, et al.. (2008). Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases. Clinical Cancer Research. 14(9). 2717–2725. 151 indexed citations

4.

Supple, Shane G., Harry Iland, Michael Barnett, & John D. Pollard. (2001). A spontaneous novel XK gene mutation in a patient with McLeod syndrome. British Journal of Haematology. 115(2). 369–372. 11 indexed citations

5.

Supple, Shane G., Eva L. Joachimsthal, Noel W. Dunn, & Peter L. Rogers. (2000). Isolation and preliminary characterization of a Zymomonas mobilis mutant with an altered preference for xylose and glucose utilization. Biotechnology Letters. 22(2). 157–164. 8 indexed citations

6.

Duan, Kangmin, et al.. (1998). Involvement of antisense RNA in replication control of the lactococcal plasmid pND324. FEMS Microbiology Letters. 164(2). 419–426. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact